PRESS RELEASE published on 09/24/2024 at 11:51, 1 year 7 months ago Original-Research: Pentixapharm Holding AG (von BankM AG): n.a. Pentixapharm Holding AG von BankM AG eingestuft. Präziser Theranostic-Ansatz mit validiertem Target. Potenzial in Präzisionsonkologie. Risikoadjustierte Bewertung des Eigenkapitals. Vollständige Analyse unter: http://www.more-ir.de/d/30855.pdf BankM AG Pentixapharm Holding AG Theranostic-Ansatz Präzisionsonkologie Bewertung Eigenkapital
BRIEF published on 09/23/2024 at 12:20, 1 year 7 months ago Pentixapharm Holding AG Sets Price Range for Planned IPO Frankfurt Stock Exchange Clinical Trials IPO Radiopharmaceuticals Pentixapharm
BRIEF published on 09/23/2024 at 12:20, 1 year 7 months ago Pentixapharm Holding AG fixe la fourchette de prix de son introduction en bourse Bourse De Francfort Essais Cliniques Introduction En Bourse Produits Radiopharmaceutiques Pentixapharm
PRESS RELEASE published on 09/23/2024 at 12:15, 1 year 7 months ago Pentixapharm Holding AG Sets Price Range for Planned IPO Pentixapharm Holding AG sets price range of EUR 4.70 to EUR 6.00 per share for planned IPO to fund product pipeline development in radioligand therapies IPO Financial Resources Price Range Pentixapharm Holding AG Radioligand Therapies
BRIEF published on 09/12/2024 at 15:05, 1 year 7 months ago Pentixapharm Holding AG Plans IPO on Frankfurt Stock Exchange Frankfurt Stock Exchange Cancer Treatment IPO Radiopharmaceuticals Phase III Trials
BRIEF published on 09/12/2024 at 15:05, 1 year 7 months ago Pentixapharm Holding AG envisage une introduction en bourse à Francfort Bourse De Francfort Introduction En Bourse Traitement Du Cancer Produits Radiopharmaceutiques Essais De Phase III
PRESS RELEASE published on 09/12/2024 at 15:00, 1 year 7 months ago Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange Pentixapharm Holding AG, a subsidiary of Eckert & Ziegler SE, plans IPO on the Prime Standard of the Frankfurt Stock Exchange, focusing on innovative radiopharmaceuticals for theranostics of various indications Frankfurt Stock Exchange IPO Radiopharmaceuticals Pentixapharm Holding AG Theranostics
Published on 05/11/2026 at 09:05, 2 hours 22 minutes ago Ameriwest Outlines Multiple Additional Breccia Pipe-Style Targets at Bornite from Historical Soil Sampling and Mapping
Published on 05/11/2026 at 08:05, 3 hours 22 minutes ago Tocvan Accelerates Gran Pilar: 5,000+ Meters Drilled to Date, Historic Workings Discovered on South Block, Pilot Progresses
Published on 05/09/2026 at 01:30, 2 days 9 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/11/2026 at 11:17, 10 minutes ago Aroundtown SA: Release of a capital market information
Published on 05/11/2026 at 11:10, 16 minutes ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy
Published on 05/11/2026 at 11:09, 17 minutes ago Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market
Published on 05/11/2026 at 11:00, 27 minutes ago Shelly Group: Invitation to Earnings Webcast/Call on 12 May 2026 on Unaudited 3M 2026 Results
Published on 05/11/2026 at 10:48, 38 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from May 4 to May 8 2026
Published on 05/11/2026 at 10:48, 38 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 4 au 8 mai 2026
Published on 05/11/2026 at 09:16, 2 hours 10 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 28 avril 2026
Published on 05/07/2026 at 19:15, 3 days 16 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 16 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote